Life Science Newsletter | May 2026

XTALKS LIFE SCIENCE NEWSLETTER

MAY 2026: This month’s Xtalks Life Science Newsletter highlights what’s shaping biotech IPOs, clinical trial strategy, AI in regulatory review and more

Note From the Editor

Vera Kovacevic, PhD

In this month’s featured editorial, we take a closer look at the return of biotech IPO activity in 2026, as companies begin to re-enter the public markets after a more cautious funding period. You’ll also find upcoming webinars covering clinical trial optimization and biopharma manufacturing, with practical perspectives on study design and execution alongside process efficiency and scale-up.

We’re also inviting you to weigh in on a timely industry question: as regulators expand their use of AI in review processes, should these tools play a larger role in accelerating drug approvals?

Explore the featured blog, register for upcoming webinars and share your view in this month’s poll.

Vera Kovacevic, PhDEditor-in-ChiefXtalks — The Life Science Community™

Upcoming Webinars

Register free for our upcoming webinars, covering a wide range of topics in pharma, biotech, medtech, healthcare and research.

May 6
CLINICAL TRIALS | DISCOVERY AND DEVELOPMENT

MRD-Driven Oncology Trials: Regulatory, Clinical and Pharmacology Considerations

Examine how sponsors can thoughtfully incorporate MRD across early-phase and registrational development.

MRD-Driven Oncology Trials: Regulatory, Clinical and Pharmacology Considerations
May 7
TRIAL DESIGN | TRIAL MANAGEMENT

AI and Emerging Technologies in Clinical Trials: Practical Applications and Regulatory Considerations

Discover a practical view of how AI, decentralized trial technologies and modeling and simulation are being used in clinical trials today.

AI and Emerging Technologies in Clinical Trials: Practical Applications and Regulatory Considerations
May 12
MANUFACTURING | PROCESS DEVELOPMENT

Media Manufacturing Strategies to Reduce GMP Transition Risk

Gain practical insights into aligning non-GMP prototyping with GMP-compliant manufacturing to support regulatory readiness.

Media Manufacturing Strategies to Reduce GMP Transition Risk

Community Poll

Cast your vote and weigh in on this month’s pressing topic facing our life science community.

Xtalks Insights

Get industry leading pharma and biotech news, events and expert insights delivered to your inbox.

What topics would you like to hear more about?

Select all that apply.

Want to get even more specific?

Help us narrow down the sub-topics that you're most interested in.

Thank you!

For webinars, videos, podcasts and more from Xtalks, join our community today.

BECOME A FREE MEMBER